Target
Apoptosis regulator Bcl-2
Ligand
BDBM232452
Substrate
n/a
Meas. Tech.
Fluorescence Polarization Assay (FPA)
Temperature
298.15±n/a K
IC50
10±n/a nM
Comments
extracted
Citation
 Borzilleri, RMCai, ZTebben, AJPerez, HLZhang, LSchroeder, GMWei, DD Substituted sulfonamides useful as antiapoptotic Bcl inhibitors US Patent  US9346795 Publication Date 5/24/2016 
Target
Name:
Apoptosis regulator Bcl-2
Synonyms:
Apoptosis regulator Bcl-2 Protein | B-cell lymphoma 2 protein (Bcl-2) | BCL-2 | BCL2 | BCL2_HUMAN | Bcl-2 Protein
Type:
Homodimer or heterodimer
Mol. Mass.:
26269.11
Organism:
Homo sapiens (Human)
Description:
P10415
Residue:
239
Sequence:
MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK
  
Inhibitor
Name:
BDBM232452
Synonyms:
US9346795, 289
Type:
Small organic molecule
Emp. Form.:
C40H40BrClN4O4S
Mol. Mass.:
788.192
SMILES:
CCCCN(CCCC)c1ccc(Br)c(n1)-c1ccc(cc1C(=O)N1CCc2ccccc2C1)C(=O)NS(=O)(=O)c1ccc2cccc(Cl)c2c1
Structure:
Search PDB for entries with ligand similarity: